Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma

MLA

Ana Acuna-Villaorduna MD, et al. “Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma.” Cancer Control, vol. 29, Oct. 2022. EBSCOhost, https://doi.org/10.1177/10732748221134411.

APA

Ana Acuna-Villaorduna MD, Viswanathan Shankar Dr.P.H, Michael Wysota MD, Amanda Jirgal BA, Rafi Kabarriti MD, Sarah Bellemare MD, Inessa Goldman MD, Andreas Kaubisch MD, Santiago Aparo MD, Sanjay Goel MD, M., & Jennifer Chuy MD. (2022). Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma. Cancer Control, 29. https://doi.org/10.1177/10732748221134411

Chicago

Ana Acuna-Villaorduna MD, Viswanathan Shankar Dr.P.H, Michael Wysota MD, Amanda Jirgal BA, Rafi Kabarriti MD, Sarah Bellemare MD, Inessa Goldman MD, et al. 2022. “Induction Chemotherapy With FOLFIRINOX Followed by Chemoradiation With Gemcitabine in Patients With Borderline-Resectable Pancreatic Ductal Adenocarcinoma.” Cancer Control 29 (October). doi:10.1177/10732748221134411.